Nothing Special   »   [go: up one dir, main page]

Hamilton et al., 2019 - Google Patents

Autoreactive B cells in SLE, villains or innocent bystanders?

Hamilton et al., 2019

View HTML
Document ID
8132459597398730357
Author
Hamilton J
Hsu H
Mountz J
Publication year
Publication venue
Immunological reviews

External Links

Snippet

The current concepts for development of autoreactive B cells in SLE (systemic lupus erythematosus) focus on extrinsic stimuli and factors that provoke B cells into tolerance loss. Traditionally, major tolerance loss pathways are thought to be regulated by factors outside …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay

Similar Documents

Publication Publication Date Title
Hamilton et al. Autoreactive B cells in SLE, villains or innocent bystanders?
Chevrier et al. IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation
Schwickert et al. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells
Roe NK‐cell exhaustion, B‐cell exhaustion and T‐cell exhaustion—the differences and similarities
Dong et al. Post-translational regulations of Foxp3 in Treg cells and their therapeutic applications
Christensen et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
Liu et al. A miR-155–Peli1–c-Rel pathway controls the generation and function of T follicular helper cells
Zotos et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell–intrinsic mechanism
Shaw et al. Regulation of lymphocyte function by ORAI and STIM proteins in infection and autoimmunity
Rothenfusser et al. Distinct CpG oligonucleotide sequences activate human γ δ T cells via interferon‐α/‐β
Carpio et al. IFN-γ and IL-21 double producing T cells are Bcl6-independent and survive into the memory phase in Plasmodium chabaudi infection
Raifer et al. Unlike αβ T cells, γδ T cells, LT i cells and NKT cells do not require IRF 4 for the production of IL‐17A and IL‐22
Petkau et al. The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins
He et al. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance
Römmler et al. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7-and TLR9-mediated immune responses of human immune cells
Pérez‐Olivares et al. Functional interplay between c‐Myc and Max in B lymphocyte differentiation
Barbieri et al. Thrombopoietin protects hematopoietic stem cells from retrotransposon-mediated damage by promoting an antiviral response
Sackesen et al. Suppression of B‐cell activation and I g E, I g A, I g G 1 and I g G 4 production by mammalian telomeric oligonucleotides
Palm et al. Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis
Calame Transcription factors that regulate memory in humoral responses
Ruck et al. K2P18. 1 translates T cell receptor signals into thymic regulatory T cell development
Zhang et al. YTHDF2/m6A/NF‐κB axis controls anti‐tumor immunity by regulating intratumoral Tregs
Barut et al. Transcriptomic profiling of bovine blood dendritic cells and monocytes following TLR stimulation
Giacomini et al. IFN‐β therapy modulates B‐cell and monocyte crosstalk via TLR 7 in multiple sclerosis patients
Sun et al. IL‐10 is required for human CD4+ CD25+ regulatory T cell‐mediated suppression of xenogeneic proliferation